Scientist/Sr. Scientist, Antibody Characterization at Manifold Bio

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Protein AnalyticsAntibody CharacterizationProtein-Protein InteractionsHigh-Throughput ScreeningRational DesignProtein StabilityDrug DeliveryMolecular Characterization

Questions & Answers

Common questions about this position

What qualifications are required for the Scientist/Sr. Scientist position?

A PhD or equivalent experience in protein biochemistry, molecular biology, biological engineering, or related field is required, along with proven expertise in protein analytics and protein-protein interactions utilizing relevant techniques.

What are the main responsibilities in this role?

Responsibilities include driving projects to investigate binding kinetics of therapeutic proteins, generating and characterizing binders, building pipelines to screen hundreds to thousands of binders, utilizing in vivo multiplexing, and collaborating cross-functionally to generate decision-enabling data.

What is the salary range for this position?

This information is not specified in the job description.

Is this position remote or onsite?

This information is not specified in the job description.

What kind of team will I be working with?

You'll join the Protein Sciences team as a core member, working with a world-class team of protein engineers, biologists, and computational scientists, and collaborating cross-functionally with program teams.

Manifold Bio

Designs precision biologics using in vivo methods

About Manifold Bio

Manifold Bio specializes in creating precision biologics for the pharmaceutical industry, focusing on drug design and development. Their main product is an in vivo drug design platform, which allows for testing drugs within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment, making it particularly effective for complex biologics. Unlike other companies, Manifold Bio's approach to drug design is distinct because it integrates in vivo testing with advanced protein multiplexing capabilities. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.

Boston, MassachusettsHeadquarters

2020Year Founded

$58.8MTotal Funding

SERIES_ACompany Stage

Biotechnology, HealthcareIndustries

11-50Employees

Risks

Increased competition from companies like Insamo and Infinimmune.

Rapid AI and ML advancements may outpace Manifold Bio's current technology.

Regulatory challenges in in vivo testing could delay product development timelines.

Differentiation

Manifold Bio uses proprietary mCodes™ technology for protein multiplexing in drug design.

Their in vivo drug design platform is the first of its kind globally.

The company specializes in precision biologics, focusing on complex biologics development.

Upsides

Raised $40M in Series A funding, indicating strong market interest.

Their platform could revolutionize in vivo testing by testing multiple molecules simultaneously.

Strategic partnerships with multiple investors enhance growth and development opportunities.

Land your dream remote job 3x faster with AI

Try Jobo Free